GLP-1 receptor agonists (GLP-1 RAs) are revolutionizing glycemic control for patients with type 2 diabetes (T2D), but with rising clinical complexity and diverse patient needs, a one-size-fits-all approach is insufficient. While every currently available GLP-1 RA is indicated for blood …
A major hurdle in managing type 2 diabetes (T2D) is a widespread gap in clinician awareness around the powerful, far-reaching benefits of GLP-1 receptor agonists (GLP-1 RAs). These innovative therapies help reduce the burden of cardiovascular, kidney, and metabolic (CKM) …
Chronic, subacute, and acute pain remain among the most common and complex challenges encountered in clinical practice. Inadequate pain management contributes to diminished quality of life, impaired function, and increased healthcare utilization. At the same time, the ongoing opioid crisis …
Unlike many other cancers, rates of anal cancer and death due to anal cancer are rising in the United States. The increasing incidence is primarily seen in high-risk populations including men who have sex with men (MSM) and people living …
New diagnoses of HIV continue at a rapid pace despite the availability of preventative options. This is particularly true among underserved populations, including racial and ethnic minorities, who often go undiagnosed or underdiagnosed due to disparities in access to care. …
Individuals from underserved communities often face roadblocks to clinical trial participation, including geographic limitations, socioeconomic barriers, restrictive eligibility criteria, and systemic inequities. These challenges are compounded by unconscious bias among health care professionals (HCPs), which can shut down vital conversations …
Unlike many other cancers, rates of anal cancer and death due to anal cancer are rising in the United States. The increasing incidence is primarily seen in high-risk populations including men who have sex with men (MSM) and people living …
There is a critical and ongoing need to educate nurses and nurse practitioners, who often form the backbone of patient care delivery, about the presence and impact of unconscious bias in clinical settings. As essential connectors within the healthcare provider …
Recent advances in the treatment of hemophilia, a genetically X-linked bleeding disorder, include non-factor prophylactic therapies such as factor VIII mimetics, anti-tissue factor pathway inhibitors (anti-TFPIs) and small interfering RNA (siRNA) treatments. Health care professionals (HCPs) treating patients with hemophilia …